Skip to main content
. Author manuscript; available in PMC: 2009 Oct 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2008 Jul 12;232(2):236–243. doi: 10.1016/j.taap.2008.06.022

Figure 3.

Figure 3

Principal components analysis of the 1H NMR spectra from (A) urine (n=4, samples were collected on days 22, 30 and 36); and (B) liver (n=3 for high fat control and alcohol, samples were collected on day 28). Each point represents and individual measurement. In the urine spectra, alcohol and its main metabolite, ethyl-glucuronide, were removed from the analysis.